Search in:

Expert Opinion on Drug Metabolism & Toxicology Volume 15, 2019 - Issue 11

Submit an article Journal homepage

Open access

39,127

Views

CrossRef citations to date

Altmetric

Review

An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations

Ann C. ChildressCenter for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USACorrespondence[email protected]
View further author information

Marina KomolovaHighland Therapeutics Inc., Toronto, ON, CanadaView further author information

F. Randy SalleeIronshore Pharmaceuticals Inc., Durham, NC, USAView further author information

Pages 937-974 | Received 11 Aug 2019, Accepted 30 Sep 2019, Published online: 08 Nov 2019

Cite this article
https://doi.org/10.1080/17425255.2019.1675636
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (26)

Anwar B. Almutairi, Naif Z. Alrashdi, Laura Vogtle & Mansour M. Alotaibi. (2023) Effect of psychostimulant medications on physical function in children with cerebral palsy: scoping review. Pediatric Research.
Crossref

Michael C. F. Smith, Raja A. S. Mukherjee, Ulrich Müller-Sedgwick, Dietmar Hank, Peter Carpenter & Marios Adamou. (2023) UK adult ADHD services in crisis. BJPsych Bulletin, pages 1-5.
Crossref

M.J. Saadh, S.M. Mohealdeen, C.Y. Hsu, U.A. Jumanazarov, R.R. MaaliwIIIIII, M. Mirzaei, M. Da'i & K. Harismah. (2023) Assessments of carbon and boron nitride graphdiyne nanosheets for exploring the amphetamine drug adsorbents/sensors along with density functional theory. Chemical Physics Impact 7, pages 100373.
Crossref

Ka-Po Wong, Bohan Zhang & Jing Qin. (2023) Unlocking Potential: The Development and User-Friendly Evaluation of a Virtual Reality Intervention for Attention-Deficit/Hyperactivity Disorder. Applied System Innovation 6:6, pages 110.
Crossref

Martin A. Katzman, Victor Otcheretko, Michelle D. Po, Cassandra L. Uchida & Bev Incledon. (2023) Adverse Events During Dosing of Delayed-Release/Extended-Release Methylphenidate: Learnings From the Open-Label Phase of a Registration Trial and a Real-World Postmarketing Surveillance Program. Clinical Therapeutics.
Crossref

Brittany M. Merrill, Fiona L. Macphee, Lisa Burrows-MacLean, Erika K. Coles, Brian T. Wymbs, Anil Chacko, Kathryn Walker, Frances Wymbs, Allison Garefino, Jessica Robb Mazzant, Elizabeth M. Gnagy, James G. Waxmonsky, Greta M. Massetti, Daniel A. Waschbusch, Gregory A. Fabiano & William E. PelhamJr.Jr.. (2023) Single and Combined Effects of Multiple Intensities of Behavioral Modification and Methylphenidate for Children with ADHD in the Home Setting. Research on Child and Adolescent Psychopathology.
Crossref

Ole Jakob Storebø, Maja Rosenberg Overby Storm, Johanne Pereira Ribeiro, Maria Skoog, Camilla Groth, Henriette E Callesen, Julie Perrine Schaug, Pernille Darling Rasmussen, Christel-Mie L Huus, Morris Zwi, Richard Kirubakaran, Erik Simonsen & Christian Gluud. (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews 2023:3.
Crossref

Henrik Uebel-von Sandersleben, Anke Mayer, Michaela Ruhmann, Oliver Dangel & Helmut Schütz. (2023) Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition Effects. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology 11:1, pages 132-142.
Crossref

Allyson L. Spence, Leticia A. Shea, Madalyn Kuhlenberg, Cassandra Stroup, Stephanie James & LaToya Jones Braun. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research 209 231 .

Vasilios Pallikaras, Conall E. Mac Cionnaith, Vanessa C. Fernandez Rosales, Andreas Arvanitogiannis & James G. Pfaus. (2022) Reciprocal effects of single or repeated exposure to methylphenidate or sex in adult male rats. Psychopharmacology 240:1, pages 227-237.
Crossref

Laura Biedermann & Daniel Turner. (2022) Eine Behandlungsoption für die Zukunft?. InFo Neurologie + Psychiatrie 24:12, pages 27-28.
Crossref

Kim E. Ono, Donald J. Bearden, Susan M. Lee, Cierra Moss, Ammar Kheder, Ivana Cernokova, Daniel L. Drane & Satyanarayana Gedela. (2022) Interventions for ADHD in children & adolescents with epilepsy: A review and decision tree to guide clinicians. Epilepsy & Behavior 135, pages 108872.
Crossref

Eun Jin Park, Young-Min Park, Seung-Hwan Lee & Bongseog Kim. (2022) The Loudness Dependence of Auditory Evoked Potentials is associated with the Symptom Severity and Treatment in Boys with Attention Deficit Hyperactivity Disorder. Clinical Psychopharmacology and Neuroscience 20:3, pages 514-525.
Crossref

Bev Incledon, Chantal Incledon, Roberto Gomeni, Cassandra L. Uchida, Amy Morris, Kim Perry & Jill Kapuscinski. (2022) Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations. Clinical Pharmacology in Drug Development 11:8, pages 966-975.
Crossref

Yuwei Xia, Yu Gong, Hanbin Wang, Shen Li & Fuqiang Mao. (2022) Family Function Impacts Relapse Tendency in Substance Use Disorder: Mediated Through Self-Esteem and Resilience. Frontiers in Psychiatry 13.
Crossref

Pozzi Marco, Mauri Maddalena, Bertella Silvana, Gatti Erika & Nobile Maria. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 256 285 .

Ana Y. Simão, Mónica Antunes, Hernâni Marques, Tiago Rosado, Sofia Soares, Joana Gonçalves, Mário Barroso & Eugenia Gallardo. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 2003 2027 .

Ana Y. Simão, Mónica Antunes, Hernâni Marques, Tiago Rosado, Sofia Soares, Joana Gonçalves, Mário Barroso & Eugenia Gallardo. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 25 .

Madeleine J. Groom & Samuele Cortese. 2022. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder 19 50 .

Silvia Grazioli, Eleonora Rosi, Maddalena Mauri, Alessandro Crippa, Federica Tizzoni, Arianna Tarabelloni, Filippo Maria Villa, Federica Chiapasco, Maria Reimers, Erika Gatti, Silvana Bertella, Massimo Molteni & Maria Nobile. (2021) Patterns of Response to Methylphenidate Administration in Children with ADHD: A Personalized Medicine Approach through Clustering Analysis. Children 8:11, pages 1008.
Crossref

Rafał R. Jaeschke, Ewelina Sujkowska & Magdalena Sowa-Kućma. (2021) Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review. Psychopharmacology 238:10, pages 2667-2691.
Crossref

Sujin Bae, Sunhye Park & Doug Hyun Han. (2021) A mixed herbal extract as an adjunctive therapy for attention deficit hyperactivity disorder: A randomized placebo-controlled trial. Integrative Medicine Research 10:3, pages 100714.
Crossref

Andreas von Heydwolff. (2021) Die Behandlung von ADHS mit Amphetamin bei ErwachsenenTreating ADHD in Adults with Amphetamines. psychopraxis. neuropraxis 24:1, pages 16-21.
Crossref

Ann C. Childress. (2021) Novel Formulations of ADHD Medications: Stimulant Selection and Management. FOCUS 19:1, pages 31-38.
Crossref

Ann C. Childress, Cassandra L. Uchida, Michelle D. Po, Norberto J. DeSousa & Bev Incledon. (2020) A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial. Clinical Therapeutics 42:12, pages 2332-2340.
Crossref

Akwete L. Adjei, Inder Chaudhary, Scott H. Kollins & Americo Padilla. (2020) A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder. Pediatric Drugs 22:5, pages 561-570.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations

Articles from other publishers (26)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations

Citations (26)

Articles from other publishers (26)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date